2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide

C31H36N4O4 — CID 57418856

IUPAC2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide
SMILESCc1ccc(-n2nc(C(C)C)cc2NC(=O)C(O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc1
InChIInChI=1S/C31H36N4O4/c1-21(2)27-20-29(35(33-27)23-10-8-22(3)9-11-23)32-31(37)30(36)26-12-13-28(25-7-5-4-6-24(25)26)39-19-16-34-14-17-38-18-15-34/h4-13,20-21,30,36H,14-19H2,1-3H3,(H,32,37)
InChIKeySIEQCLZRTXMYPL-UHFFFAOYSA-N
MW528.65 g/mol
LogP4.84
Rot. Bonds9

About 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide

2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide (PubChem CID 57418856) has the molecular formula C31H36N4O4 and a molecular weight of 528.65 g/mol. Its IUPAC name is 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide.

Molecular Properties

Compound Name2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide
PubChem CID57418856
Molecular FormulaC31H36N4O4
Molecular Weight528.65 g/mol
Exact Mass528.27
IUPAC Name2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide
SMILESCc1ccc(-n2nc(C(C)C)cc2NC(=O)C(O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc1
InChIInChI=1S/C31H36N4O4/c1-21(2)27-20-29(35(33-27)23-10-8-22(3)9-11-23)32-31(37)30(36)26-12-13-28(25-7-5-4-6-24(25)26)39-19-16-34-14-17-38-18-15-34/h4-13,20-21,30,36H,14-19H2,1-3H3,(H,32,37)
InChIKeySIEQCLZRTXMYPL-UHFFFAOYSA-N
XLogP4.84
TPSA88.85 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500528.65
LogP ≤ 54.84
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide?
The IUPAC name of 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide (CID 57418856) is 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide.
What is the SMILES notation for 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide?
The canonical SMILES for 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide is Cc1ccc(-n2nc(C(C)C)cc2NC(=O)C(O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc1.
What is the InChIKey of 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide?
The InChIKey is SIEQCLZRTXMYPL-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H36N4O4/c1-21(2)27-20-29(35(33-27)23-10-8-22(3)9-11-23)32-31(37)30(36)26-12-13-28(25-7-5-4-6-24(25)26)39-19-16-34-14-17-38-18-15-34/h4-13,20-21,30,36H,14-19H2,1-3H3,(H,32,37).
What are the key properties of 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide?
2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide has a molecular weight of 528.65 g/mol, XLogP of 4.84, 9 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-hydroxy-N-[1-(4-methylphenyl)-3-propan-2-ylpyrazol-5-yl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]acetamide is sourced from PubChem (CID 57418856), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).